Sort
40,608 grants matching “prostate cancer”
Influence of bone microenvironment on drug resistance in prostate cancer bone metastasis
$346,350Xiaohong Li · University Of Toledo Health Sci Campus · R01 · FY2023 · CA
Aggressive prostate cancer of African Americans is correlated with regulation of Immunoregulatory Genes in stroma
$346,350Farah Bakhshian Rahmatpanah · University Of California-Irvine · R01 · FY2023 · CA
CHARACTERIZATION OF GENE EXPRESSION PATTERNS OF MICROENVIRONMENT IN METASTASIZED OSTEOBLASTIC PROSTATE CANCER
$346,347The Univeristy Of Texas M.D. Anderson Cancer Center · · FY2008 · Department of Defense
Tissue and Specimen Core
$346,335Robert Vessella · Fred Hutchinson Cancer Research Center · P50 · FY2010 · CA
Angiogenin-induced RNA cleavage in cancer
$346,327Paul J. Anderson · Brigham And Women'S Hospital · R01 · FY2014 · CA
KGF in Prostate Cancer: A Transgenic Animal Model
$346,317Norman Michael Greenberg · Fred Hutchinson Cancer Research Center · R01 · FY2006 · CA
Omega-3 PUFA-gene interaction in prostate cancer
$346,299Yong Q Chen · Wake Forest University Health Sciences · R01 · FY2014 · CA
Clinical Fellowship Training Program
$346,240Peter Pinto · Division Of Basic Sciences - Nci · ZIE · FY2009 · CA
Radiation Force Imaging of Prostate Cancer and Guidance of Biopsy Procedures
$346,205Kathryn R Nightingale · Duke University · R01 · FY2013 · CA
Integrin-mediated mechanisms of prostate cancer progression
$346,194Lucia R Languino · Thomas Jefferson University · R01 · FY2019 · CA
Cell Growth Inhibiton and Estrogen Action
$346,150Baylor College Of Medicine · R01 · FY2003 · CA
Hemostatic Factors Drive Prostate Cancer Pathogenesis
$346,144Joseph S Palumbo · Cincinnati Childrens Hosp Med Ctr · R01 · FY2019 · CA
Multiparametric MRI-guided Prostate HDR Brachytherapy with Focal Tumor Boost
$346,144Xiaofeng Yang · Emory University · R01 · FY2019 · CA
GSTP1-induced S-glutathionylation in lung cancer
$346,144Adrianus (jos)l.j. Van Der Velden · University Of Vermont & St Agric College · R01 · FY2019 · CA
Analytic diagnosis methods for disease ruling
$346,124Yijian Huang · Emory University · R01 · FY2024 · CA
Integrated analysis of cancer risk and mortality in WTC survivors
$346,114Yongzhao Shao · New York University School Of Medicine · U01 · FY2024 · OH
Project 1- Role of fat in metastatic engraftment and expansion in the liver
$346,096Neil A Bhowmick · Cedars-Sinai Medical Center · P01 · FY2020 · CA
Project 3 - HDAC/GSK-3B/YAP signaling network in the liver metastatic microenvironment
$346,091Stephen J Pandol · Cedars-Sinai Medical Center · P01 · FY2020 · CA
Validation of Digital Morphometry for Cancer Risk in Benign Prostate Biopsies
$346,053Peter H. Gann · University Of Illinois At Chicago · R01 · FY2015 · CA
TARGETING GPR30 IN ABIRATERONE- AND MDV3100-RESISTANT PROSTATE CANCER
$346,049University Of Washington · · FY2014 · Department of the Army
Research Training in Neuro-Oncology
$346,009Henry S. Friedman · Duke University · T32 · FY2014 · CA
Synthesis, StructUre and Replication of Carcirogen-Modified Oligonucleotides
$346,005Carmelo J Rizzo · Vanderbilt University · R01 · FY2011 · ES
Improving chemotherapy of castration-resistant prostate cancer
$345,987Xiaoqi Liu · University Of Kentucky · R01 · FY2018 · CA
Precision Interception of Aggressive Prostate Cancer in African American Men
$345,971Franklin W Huang · Dana-Farber Cancer Inst · P20 · FY2018 · CA
p85/p110 PI3 Kinase-Structure, function and Physiology
$345,936Jonathan M. Backer · Albert Einstein College Of Medicine · R01 · FY2011 · GM